無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

呼吸器系疾患用医薬品:抗喘息薬・COPD薬・咳止め&風邪薬

Respiratory Diseases Drugs Global Market Report 2018

発行 The Business Research Company 商品コード 531335
出版日 ページ情報 英文 125 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.94円で換算しております。
Back to Top
呼吸器系疾患用医薬品:抗喘息薬・COPD薬・咳止め&風邪薬 Respiratory Diseases Drugs Global Market Report 2018
出版日: 2018年02月01日 ページ情報: 英文 125 Pages
概要

当レポートでは、世界の呼吸器系疾患用医薬品の市場を調査し、市場の定義と概要、市場への各種影響因子の分析、薬剤/疾患区分・地域・国別の動向と市場規模の推移と予測、マクロ経済因子・ヘルスケア市場全体・各種産業指標との比較、競合環境、企業プロファイルなどをまとめています。

第1章 市場の特徴

第2章 市場規模・成長率

  • 市場成長:これまでの経緯
    • 成長推進因子
    • 成長抑制因子
  • 市場成長:予測
    • 成長推進因子
    • 成長抑制因子

第3章 PESTLE分析

第4章 顧客情報

第5章 呼吸器系疾患用医薬品市場の分析:区分別

  • 世界市場の実績:区分別
    • 抗喘息薬・COPD薬
    • 咳止め・風邪薬
  • 世界市場の推移と予測:区分別
  • 市場動向・戦略

第6章 呼吸器系疾患用医薬品市場の分析:地域・国別分析

  • 世界市場の実績:地域別
  • 世界市場の推移と予測:地域別
  • 市場実績:国別
  • 市場の推移と予測:国別
  • 世界の医薬品市場の実績:区分・地域別
  • 世界の医薬品市場の実績:区分・国別

第7章 マクロ経済因子と市場の比較

  • 市場規模のGDPに占める割合
  • 一人当たりの平均支出額

第8章 マクロ経済因子と市場の比較:国別

  • 市場規模のGDPに占める割合:国別
  • 一人当たりの平均支出額:国別

第9章 産業指標と市場の比較

  • 世界の薬剤師数:国別
  • 市場収益 vs 薬剤師数:国別
  • 世界の医薬品会社数:国別
  • 市場収益 vs 医薬品会社数:国別
  • 世界のR&D/製品開発への平均支出額:国別
  • 市場収益 vs R&D/製品開発への平均支出額:国別
  • 世界のジェネリック&ブランド売上の割合:国別
  • 市場収益 vs ジェネリック&ブランド売上の割合:国別
  • 喘息の有病者数:国別
  • 世界の一般開業医の数:国別
  • 市場収益 vs 一般開業医数:国別

第10章 アジア太平洋市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • 中国
  • インド
  • 日本
  • オーストラリア

第11章 西欧市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン

第12章 東欧市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • ロシア

第13章 北米市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • 米国

第14章 南米市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • ブラジル

第15章 中東市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別

第16章 アフリカ市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別

第17章 競合環境

  • 企業プロファイル
  • GlaxoSmithKline
  • Novartis Ag
  • Pfizer Inc.
  • Boehringer Ingelheim
  • Astrazeneca Plc

第18章 主要M&A:呼吸器系疾患用医薬品市場

第19章 市場背景:医薬品市場

第20章 医薬品産業のファイナンシャルマージン

第21章 付録

目次

Respiratory Diseases Drugs Market Global Report 2018 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global respiratory diseases drugs market.

Where is the largest and fastest growing market for the respiratory diseases drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The respiratory diseases drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider Healthcare market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The respiratory diseases drugs market section of the report gives context. It compares the respiratory diseases drugs market with other segments of the Healthcare market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Respiratory Diseases Drugs Indicators Comparison.

Scope:

Markets Covered: Anti-Asthmatics And COPD Drugs; Cough And Cold Preparations

Companies Mentioned: GlaxosmithKline Plc,AstraZeneca Plc,Merck & Co,Novartis AG,Johnson & Johnson

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Respiratory Diseases Drugs Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Reasons to Purchase:

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

1. Respiratory Diseases Drugs Market Characteristics

2. Respiratory Diseases Drugs Market Size And Growth

  • 2.1. Historic Market Growth, Value ($ Billion) and Volume (Million Units)
    • 2.1.1. Drivers Of The Market
    • 2.1.2. Restraints On The Market
  • 2.2. Forecast Market Growth, Value ($ Billion)
    • 2.2.1. Drivers Of The Market
    • 2.2.2. Restraints On The Market

3. Respiratory Diseases Drugs Trends And Strategies

4. Pestle Analysis

  • 4.1. Political
  • 4.2. Economic
  • 4.3. Social
  • 4.4. Technological
  • 4.5. Legal
  • 4.6. Environmental

5. Respiratory Diseases Drugs Market Customer Information

6. Respiratory Diseases Drugs Market Regional And Country Analysis

  • 6.1. Global Respiratory Diseases Drugs Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
  • 6.2. Global Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, By Region
  • 6.3. Global Respiratory Diseases Drugs Market, Growth And Market Share Comparison, By Region
  • 6.4. Global Respiratory Diseases Drugs Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
  • 6.5. Global Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, By Country
  • 6.6. Global Respiratory Diseases Drugs Market, Growth And Market Share Comparison, By Country

7. Respiratory Diseases Drugs Market Segmentation

  • 7.1. Global Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

  • 7.2. Global Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

8. Respiratory Diseases Drugs Market Segments

  • 8.1.Anti-Asthmatics And COPD Drugs

a) Market Characteristics

b) Market Trends & Strategies

c) Global Anti-Asthmatics And COPD Drugs Market, 2017, By Segment, Value ($ Billion)

  • 8.2.Cough And Cold Preparations

a) Market Characteristics

b) Market Trends & Strategies

c) Global Cough And Cold Preparations Market, 2017, By Segment, Value ($ Billion)

9. Global Respiratory Diseases Drugs Market Comparison With Macro Economic Factors

  • 9.1. Respiratory Diseases Drugs Market Size, Percentage Of GDP, Global
  • 9.2. Per Capita Average Respiratory Diseases Drugs Expenditure, Global

10. Respiratory Diseases Drugs Market Comparison With Macro Economic Factors Across Countries

  • 10.1. Respiratory Diseases Drugs Market Size, Percentage Of GDP, By Country
  • 10.2. Per Capita Average Respiratory Diseases Drugs Expenditure, By Country

11. Respiratory Diseases Drugs Market Comparison With Industry Metrics

  • 11.1. Global Number Of Pharmacists, 2017, By Country
  • 11.2. Global Respiratory Diseases Market Revenue Versus Number Of Pharmacists, 2017, By Country
  • 11.3. Global Number Of Pharma Enterprises, 2017, By Country
  • 11.4. Global Respiratory Diseases Market Revenue Versus Number Of Pharma Enterprises, 2017, By Country
  • 11.5. Global Average Spending On R&D/Product Development, 2017, By Country
  • 11.6. Global Respiratory Diseases Market Revenue Versus Average Spending On R&D/Product Development, 2017, By Country
  • 11.7. Global Generic & Branded Sales Proportion By Country (Value), 2017, By Country
  • 11.8. Global Respiratory Diseases Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2017, By Country
  • 11.9. Prevalent Cases of Asthma, 2014, By Country
  • 11.10. Global Number Of General Practitioners 2017, By Country
  • 11.11. Global Respiratory Diseases Market Revenue Versus Number Of General Practitioners, 2017, By Country

12. Asia-Pacific Respiratory Diseases Drugs Market

    • 12.1.1. Asia-Pacific Respiratory Diseases Drugs Market Overview
    • 12.1.2. Asia-Pacific Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.1.3. Asia-Pacific Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.1.4. Asia-Pacific Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 12.1.5. Asia-Pacific Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.2. Asia-Pacific Respiratory Diseases Drugs Market: Country Analysis
  • 12.3. China Respiratory Diseases Drugs Market
    • 12.3.1. China Respiratory Diseases Drugs Market Overview
    • 12.3.2. China Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.3.3. China Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.3.4. China Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 12.3.5. China Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.4. India Respiratory Diseases Drugs Market
    • 12.4.1. India Respiratory Diseases Drugs Market Overview
    • 12.4.2. India Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.4.3. India Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.4.4. India Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 12.4.5. India Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.5. Japan Respiratory Diseases Drugs Market
    • 12.5.1. Japan Respiratory Diseases Drugs Market Overview
    • 12.5.2. Japan Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.5.3. Japan Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.5.4. Japan Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 12.5.5. Japan Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.6. Australia Respiratory Diseases Drugs Market
    • 12.6.1. Australia Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.6.2. Australia Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.6.3. Australia Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 12.6.4. Australia Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

13. Western Europe Respiratory Diseases Drugs Market

    • 13.1.1. Western Europe Respiratory Diseases Drugs Market Overview
    • 13.1.2. Western Europe Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.1.3. Western Europe Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.1.4. Western Europe Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 13.1.5. Western Europe Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.2. Western Europe Respiratory Diseases Drugs Market: Country Analysis
  • 13.3. UK Respiratory Diseases Drugs Market
    • 13.3.1. UK Respiratory Diseases Drugs Market Overview
    • 13.3.2. UK Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.3.3. UK Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.3.4. UK Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 13.3.5. UK Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.4. Germany Respiratory Diseases Drugs Market
    • 13.4.1. Germany Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.4.2. Germany Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.4.3. Germany Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 13.4.4. Germany Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.5 France Respiratory Diseases Drugs Market
    • 13.5.1 France Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.5.2 France Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.5.3. France Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 13.5.4. France Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.6. Italy Respiratory Diseases Drugs Market
    • 13.6.1. Italy Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.6.2. Italy Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.6.3. Italy Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 13.6.4. Italy Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.7. Spain Respiratory Diseases Drugs Market
    • 13.7.1. Spain Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.7.2. Spain Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.7.3. Spain Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 13.7.4. Spain Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

14. Eastern Europe Respiratory Diseases Drugs Market

    • 14.1.1. Eastern Europe Respiratory Diseases Drugs Market Overview
    • 14.1.2. Eastern Europe Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 14.1.3. Eastern Europe Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 14.1.4. Eastern Europe Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 14.1.5. Eastern Europe Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 14.2. Eastern Europe Respiratory Diseases Drugs Market: Country Analysis
  • 14.3. Russia Respiratory Diseases Drugs Market
    • 14.3.1. Russia Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 14.3.2. Russia Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 14.3.3. Russia Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 14.3.4. Russia Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

15. North America Respiratory Diseases Drugs Market

    • 15.1.1. North America Respiratory Diseases Drugs Market Overview
    • 15.1.2. North America Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 15.1.3. North America Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 15.1.4. North America Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 15.1.5. North America Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 15.2. North America Respiratory Diseases Drugs Market: Country Analysis
  • 15.3. USA Respiratory Diseases Drugs Market
    • 15.3.1. USA Respiratory Diseases Drugs Market Overview
    • 15.3.2. USA Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 15.3.3. USA Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 15.3.4. USA Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 15.3.5. USA Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

16. South America Respiratory Diseases Drugs Market

    • 16.1.1. South America Respiratory Diseases Drugs Market Overview
    • 16.1.2. South America Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 16.1.3. South America Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 16.1.4. South America Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 16.1.5. South America Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 16.2. South America Respiratory Diseases Drugs Market: Country Analysis
  • 16.3. Brazil Respiratory Diseases Drugs Market
    • 16.3.1. Brazil Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 16.3.2. Brazil Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 16.3.3. Brazil Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 16.3.4. Brazil Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

17. Middle East Respiratory Diseases Drugs Market

    • 17.1.1. Middle East Respiratory Diseases Drugs Market Overview
    • 17.1.2. Middle East Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 17.1.3. Middle East Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 17.1.4. Middle East Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 17.1.5. Middle East Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

18. Africa Respiratory Diseases Drugs Market

    • 18.1.1. Africa Respiratory Diseases Drugs Market Overview
    • 18.1.2. Africa Respiratory Diseases Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 18.1.3. Africa Respiratory Diseases Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 18.1.4. Africa Respiratory Diseases Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

    • 18.1.5. Africa Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

19. Respiratory Diseases Drugs Market Competitive Landscape

  • 19.1. Company Profiles
  • 19.2. GlaxosmithKline Plc
    • 19.2.1. Overview
    • 19.2.2. Products And Services
    • 19.2.3. Strategy
    • 19.2.4. Financial Performance
  • 19.3. AstraZeneca Plc
    • 19.3.1. Overview
    • 19.3.2. Products And Services
    • 19.3.3. Strategy
    • 19.3.4. Financial Performance
  • 19.4. Merck & Co
    • 19.4.1. Overview
    • 19.4.2. Products And Services
    • 19.4.3. Strategy
    • 19.4.4. Financial Performance
  • 19.5. Novartis AG
    • 19.5.1. Overview
    • 19.5.2. Products And Services
    • 19.5.3. Strategy
    • 19.5.4. Financial Performance
  • 19.6. Johnson & Johnson
    • 19.6.1. Overview
    • 19.6.2. Products And Services
    • 19.6.3. Strategy
    • 19.6.4. Financial Performance

20. Key Mergers And Acquisitions In The Respiratory Diseases Drugs Market

21. Market Background: Respiratory Diseases Drugs Market

    • 21.1.1. Respiratory Diseases Drugs Market Characteristics
    • 21.1.2. Respiratory Diseases Drugs Market Historic Growth, Value ($ Billion)
      • 21.1.2.1. Drivers Of The Market
      • 21.1.2.2. Restraints Of The Market
    • 21.1.3. Respiratory Diseases Drugs Market Forecast Growth, Value ($ Billion)
      • 21.1.3.1. Drivers Of The Market
      • 21.1.3.2. Restraints Of The Market
    • 21.1.4. Respiratory Diseases Drugs Trends And Strategies
  • 21.2. Respiratory Diseases Drugs Market Regional And Country Analysis
    • 21.2.1. Global Respiratory Diseases Drugs Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
    • 21.2.2. Global Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, By Region
    • 21.2.3. Respiratory Diseases Drugs Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
    • 21.2.4. Respiratory Diseases Drugs Market, 2013 - 2021, Historic And Forecast, By Country
    • 21.2.5. Respiratory Diseases Drugs Market, Growth And Market Share Comparison, By Segment
    • 21.2.6. Respiratory Diseases Drugs Market, Growth And Market Share Comparison, By Country And Segment
  • 21.3. Global Respiratory Diseases Drugs Market Comparison With Macro Economic Factors
    • 21.3.1. Respiratory Diseases Drugs Market Size, Percentage Of GDP, Global
    • 21.3.2. Per Capita Average Respiratory Diseases Drugs Expenditure, Global
  • 21.4. Respiratory Diseases Drugs Market Comparison With Macro Economic Factors Across Countries
    • 21.4.1. Respiratory Diseases Drugs Market Size, Percentage Of GDP, By Country
    • 21.4.2. Per Capita Average Respiratory Diseases Drugs Expenditure, By Country
  • 21.5. Key Mergers And Acquisitions In The Respiratory Diseases Drugs Market

22. Appendix

  • 22.1. NAICS Definitions Of Industry Covered In This Report
  • 22.2. Abbreviations
  • 22.3. Currencies
  • 22.4. Research Inquiries
  • 22.5. The Business Research Company
  • 22.6. Copyright And Disclaimer
Back to Top